Overview
Sujay Kansagra, MD is a professor at Duke and the director the Pediatric Neurology Sleep Medicine Program. He is an active clinician and researcher. He specializes in treating a variety of sleep disorders, including sleep apnea, insomnia, narcolepsy and parasomnias. His prior clinical research involves sleep pathology in rare conditions such as alternating hemiplegia of childhood and infantile Pompe disease. He has also served as the Duke PI on mult-centered pharmacologic trials involving migraine and narcolepsy. Dr. Kansagra is the author of numerous peer-reviewed research publications and 5 books. He is currently doing research on novel technology that helps with behavioral insomnia of childhood.
Current Appointments & Affiliations
Professor of Pediatrics
·
2023 - Present
Pediatrics, Neurology,
Pediatrics
Recent Publications
Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy.
Journal Article J Clin Sleep Med · March 1, 2024 STUDY OBJECTIVES: We examined body mass index (BMI) changes associated with sodium oxybate treatment (SXB) in pediatric patients with narcolepsy with cataplexy who participated in a double-blind, placebo-controlled, randomized withdrawal study and an open- ... Full text Link to item CiteThe microRNA processor DROSHA is a candidate gene for a severe progressive neurological disorder.
Journal Article Hum Mol Genet · August 25, 2022 DROSHA encodes a ribonuclease that is a subunit of the Microprocessor complex and is involved in the first step of microRNA (miRNA) biogenesis. To date, DROSHA has not yet been associated with a Mendelian disease. Here, we describe two individuals with pro ... Full text Open Access Link to item CiteImpact of daily caffeine intake and timing on electroencephalogram-measured sleep in adolescents.
Journal Article J Clin Sleep Med · March 1, 2022 STUDY OBJECTIVES: Caffeine use is ubiquitous among adolescents and may be harmful to sleep, with downstream implications for health and development. Research has been limited by self-reported and/or aggregated measures of sleep and caffeine collected at a ... Full text Link to item CiteRecent Grants
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of Xyrem with an Open-Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects with Narcolepsy with Cataplexy
Clinical TrialPrincipal Investigator · Awarded by Jazz Pharmaceuticals · 2015 - 2019Ph I Zecuity
Clinical TrialPrincipal Investigator · Awarded by Nupathe · 2013 - 2016View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2006
M.D.